nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN2C—nerve—hypothyroidism	0.0239	0.11	CbGeAlD
Acamprosate—GRIN2B—nerve—hypothyroidism	0.0189	0.0866	CbGeAlD
Acamprosate—GRIN2A—nerve—hypothyroidism	0.0165	0.0757	CbGeAlD
Acamprosate—GRIN2C—CREB phosphorylation through the activation of CaMKII—NEFL—hypothyroidism	0.0138	0.0354	CbGpPWpGaD
Acamprosate—GRIN2C—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.0138	0.0354	CbGpPWpGaD
Acamprosate—Muscle twitching—Liothyronine—hypothyroidism	0.0132	0.0336	CcSEcCtD
Acamprosate—GRIN2D—CREB phosphorylation through the activation of CaMKII—NEFL—hypothyroidism	0.0128	0.0329	CbGpPWpGaD
Acamprosate—GRIN2D—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.0128	0.0329	CbGpPWpGaD
Acamprosate—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—hypothyroidism	0.0126	0.0324	CbGpPWpGaD
Acamprosate—GRIN2D—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—hypothyroidism	0.0117	0.0301	CbGpPWpGaD
Acamprosate—GRIN3B—testis—hypothyroidism	0.0114	0.0523	CbGeAlD
Acamprosate—Phlebitis—Liothyronine—hypothyroidism	0.0109	0.0278	CcSEcCtD
Acamprosate—GRIN2A—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.0105	0.027	CbGpPWpGaD
Acamprosate—GRIN2A—CREB phosphorylation through the activation of CaMKII—NEFL—hypothyroidism	0.0105	0.027	CbGpPWpGaD
Acamprosate—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—hypothyroidism	0.00963	0.0247	CbGpPWpGaD
Acamprosate—GRIN1—CREB phosphorylation through the activation of CaMKII—NEFL—hypothyroidism	0.00918	0.0236	CbGpPWpGaD
Acamprosate—GRIN1—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.00918	0.0236	CbGpPWpGaD
Acamprosate—GRIN2C—adrenal cortex—hypothyroidism	0.00917	0.0421	CbGeAlD
Acamprosate—GRIN2C—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.009	0.0231	CbGpPWpGaD
Acamprosate—GRIN2B—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.00895	0.023	CbGpPWpGaD
Acamprosate—GRIN2B—CREB phosphorylation through the activation of CaMKII—NEFL—hypothyroidism	0.00895	0.023	CbGpPWpGaD
Acamprosate—GRM5—blood—hypothyroidism	0.00868	0.0398	CbGeAlD
Acamprosate—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—hypothyroidism	0.0084	0.0216	CbGpPWpGaD
Acamprosate—GRIN2D—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00836	0.0215	CbGpPWpGaD
Acamprosate—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—hypothyroidism	0.00819	0.021	CbGpPWpGaD
Acamprosate—Angina pectoris—Liothyronine—hypothyroidism	0.00792	0.0202	CcSEcCtD
Acamprosate—GRIN2C—Post NMDA receptor activation events—NEFL—hypothyroidism	0.0074	0.019	CbGpPWpGaD
Acamprosate—GRM5—testis—hypothyroidism	0.00718	0.033	CbGeAlD
Acamprosate—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00714	0.0182	CcSEcCtD
Acamprosate—Myocardial infarction—Liothyronine—hypothyroidism	0.0071	0.0181	CcSEcCtD
Acamprosate—GRIN2D—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00688	0.0177	CbGpPWpGaD
Acamprosate—GRIN2A—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00687	0.0176	CbGpPWpGaD
Acamprosate—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00682	0.0175	CbGpPWpGaD
Acamprosate—GRM5—cerebellum—hypothyroidism	0.00663	0.0304	CbGeAlD
Acamprosate—GRIN2C—thyroid gland—hypothyroidism	0.00639	0.0293	CbGeAlD
Acamprosate—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00634	0.0163	CbGpPWpGaD
Acamprosate—GRIN2A—heart—hypothyroidism	0.00613	0.0281	CbGeAlD
Acamprosate—SLC36A1—heart—hypothyroidism	0.00609	0.0279	CbGeAlD
Acamprosate—GRIN1—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00599	0.0154	CbGpPWpGaD
Acamprosate—Abscess—Liotrix—hypothyroidism	0.00591	0.0151	CcSEcCtD
Acamprosate—GRIN2B—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00584	0.015	CbGpPWpGaD
Acamprosate—GRIN2A—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00565	0.0145	CbGpPWpGaD
Acamprosate—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00555	0.0141	CcSEcCtD
Acamprosate—Hyperkinesia—Levothyroxine—hypothyroidism	0.00555	0.0141	CcSEcCtD
Acamprosate—GRIN2C—testis—hypothyroidism	0.00547	0.0251	CbGeAlD
Acamprosate—SLC36A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—hypothyroidism	0.0053	0.0136	CbGpPWpGaD
Acamprosate—SLC36A1—gonad—hypothyroidism	0.00521	0.0239	CbGeAlD
Acamprosate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00521	0.0134	CbGpPWpGaD
Acamprosate—GRIN2D—testis—hypothyroidism	0.00509	0.0233	CbGeAlD
Acamprosate—GRIN2C—cerebellum—hypothyroidism	0.00505	0.0232	CbGeAlD
Acamprosate—GRIN1—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00493	0.0127	CbGpPWpGaD
Acamprosate—Creatinine increased—Liotrix—hypothyroidism	0.00492	0.0125	CcSEcCtD
Acamprosate—Increased appetite—Levothyroxine—hypothyroidism	0.00492	0.0125	CcSEcCtD
Acamprosate—Increased appetite—Dextrothyroxine—hypothyroidism	0.00492	0.0125	CcSEcCtD
Acamprosate—Hypertension—Liothyronine—hypothyroidism	0.00489	0.0125	CcSEcCtD
Acamprosate—GRIN2B—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00481	0.0123	CbGpPWpGaD
Acamprosate—GRIN3A—testis—hypothyroidism	0.00478	0.022	CbGeAlD
Acamprosate—Muscle twitching—Liotrix—hypothyroidism	0.00477	0.0121	CcSEcCtD
Acamprosate—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00473	0.0121	CcSEcCtD
Acamprosate—Cardiac failure—Levothyroxine—hypothyroidism	0.00473	0.0121	CcSEcCtD
Acamprosate—GRIN2D—cerebellum—hypothyroidism	0.0047	0.0216	CbGeAlD
Acamprosate—GRIN2A—adrenal gland—hypothyroidism	0.00457	0.021	CbGeAlD
Acamprosate—SLC36A1—adrenal gland—hypothyroidism	0.00454	0.0208	CbGeAlD
Acamprosate—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00454	0.0117	CbGpPWpGaD
Acamprosate—Tachycardia—Liothyronine—hypothyroidism	0.00451	0.0115	CcSEcCtD
Acamprosate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00443	0.0114	CbGpPWpGaD
Acamprosate—SLC36A1—thyroid gland—hypothyroidism	0.00438	0.0201	CbGeAlD
Acamprosate—SLC36A1—Amino acid and oligopeptide SLC transporters—SLC5A5—hypothyroidism	0.00435	0.0112	CbGpPWpGaD
Acamprosate—Hypotension—Liothyronine—hypothyroidism	0.00432	0.011	CcSEcCtD
Acamprosate—SLC36A1—female gonad—hypothyroidism	0.00424	0.0194	CbGeAlD
Acamprosate—GRIN1—cerebellum—hypothyroidism	0.00419	0.0192	CbGeAlD
Acamprosate—Hyperkinesia—Liotrix—hypothyroidism	0.00408	0.0104	CcSEcCtD
Acamprosate—GRIN2B—cerebellum—hypothyroidism	0.004	0.0183	CbGeAlD
Acamprosate—Dysphagia—Levothyroxine—hypothyroidism	0.00399	0.0102	CcSEcCtD
Acamprosate—Dysphagia—Dextrothyroxine—hypothyroidism	0.00399	0.0102	CcSEcCtD
Acamprosate—Phlebitis—Liotrix—hypothyroidism	0.00394	0.01	CcSEcCtD
Acamprosate—Angina pectoris—Levothyroxine—hypothyroidism	0.00389	0.00991	CcSEcCtD
Acamprosate—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00389	0.00991	CcSEcCtD
Acamprosate—GRIN2A—testis—hypothyroidism	0.00378	0.0174	CbGeAlD
Acamprosate—SLC36A1—testis—hypothyroidism	0.00376	0.0172	CbGeAlD
Acamprosate—Renal failure acute—Liotrix—hypothyroidism	0.00368	0.00938	CcSEcCtD
Acamprosate—Body temperature increased—Liothyronine—hypothyroidism	0.00365	0.00931	CcSEcCtD
Acamprosate—Increased appetite—Liotrix—hypothyroidism	0.00362	0.00921	CcSEcCtD
Acamprosate—Weight decreased—Levothyroxine—hypothyroidism	0.00361	0.0092	CcSEcCtD
Acamprosate—Weight decreased—Dextrothyroxine—hypothyroidism	0.00361	0.0092	CcSEcCtD
Acamprosate—SLC36A1—liver—hypothyroidism	0.00355	0.0163	CbGeAlD
Acamprosate—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00351	0.00894	CcSEcCtD
Acamprosate—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00351	0.00894	CcSEcCtD
Acamprosate—GRIN2A—cerebellum—hypothyroidism	0.00349	0.016	CbGeAlD
Acamprosate—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00349	0.00889	CcSEcCtD
Acamprosate—Myocardial infarction—Levothyroxine—hypothyroidism	0.00349	0.00889	CcSEcCtD
Acamprosate—Cardiac failure—Liotrix—hypothyroidism	0.00348	0.00887	CcSEcCtD
Acamprosate—SLC36A1—cerebellum—hypothyroidism	0.00347	0.0159	CbGeAlD
Acamprosate—Sweating—Dextrothyroxine—hypothyroidism	0.00341	0.0087	CcSEcCtD
Acamprosate—Sweating—Levothyroxine—hypothyroidism	0.00341	0.0087	CcSEcCtD
Acamprosate—GABRG2—pituitary gland—hypothyroidism	0.00322	0.0148	CbGeAlD
Acamprosate—Blood creatinine increased—Liotrix—hypothyroidism	0.00318	0.00811	CcSEcCtD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00298	0.00764	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00297	0.00762	CbGpPWpGaD
Acamprosate—GABRB3—heart—hypothyroidism	0.00296	0.0136	CbGeAlD
Acamprosate—Abdominal distension—Liotrix—hypothyroidism	0.00296	0.00753	CcSEcCtD
Acamprosate—GRM5—G alpha (q) signalling events—TRH—hypothyroidism	0.00294	0.00755	CbGpPWpGaD
Acamprosate—Dysphagia—Liotrix—hypothyroidism	0.00294	0.00748	CcSEcCtD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00286	0.00734	CbGpPWpGaD
Acamprosate—Angina pectoris—Liotrix—hypothyroidism	0.00286	0.00729	CcSEcCtD
Acamprosate—Bronchitis—Liotrix—hypothyroidism	0.00282	0.0072	CcSEcCtD
Acamprosate—Alopecia—Levothyroxine—hypothyroidism	0.00282	0.00719	CcSEcCtD
Acamprosate—Alopecia—Dextrothyroxine—hypothyroidism	0.00282	0.00719	CcSEcCtD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00277	0.00711	CbGpPWpGaD
Acamprosate—GRIN2B—ErbB4 signaling events—PRL—hypothyroidism	0.00275	0.00707	CbGpPWpGaD
Acamprosate—Tension—Levothyroxine—hypothyroidism	0.00273	0.00696	CcSEcCtD
Acamprosate—Tension—Dextrothyroxine—hypothyroidism	0.00273	0.00696	CcSEcCtD
Acamprosate—Nervousness—Dextrothyroxine—hypothyroidism	0.0027	0.00688	CcSEcCtD
Acamprosate—Nervousness—Levothyroxine—hypothyroidism	0.0027	0.00688	CcSEcCtD
Acamprosate—Weight decreased—Liotrix—hypothyroidism	0.00266	0.00677	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00263	0.00676	CbGpPWpGaD
Acamprosate—Tremor—Levothyroxine—hypothyroidism	0.00261	0.00664	CcSEcCtD
Acamprosate—Tremor—Dextrothyroxine—hypothyroidism	0.00261	0.00664	CcSEcCtD
Acamprosate—Acute coronary syndrome—Liotrix—hypothyroidism	0.00258	0.00658	CcSEcCtD
Acamprosate—Myocardial infarction—Liotrix—hypothyroidism	0.00257	0.00654	CcSEcCtD
Acamprosate—SLC36A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—hypothyroidism	0.00256	0.00657	CbGpPWpGaD
Acamprosate—Agitation—Dextrothyroxine—hypothyroidism	0.00256	0.00651	CcSEcCtD
Acamprosate—Agitation—Levothyroxine—hypothyroidism	0.00256	0.00651	CcSEcCtD
Acamprosate—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00255	0.00655	CbGpPWpGaD
Acamprosate—Angioedema—Dextrothyroxine—hypothyroidism	0.00254	0.00648	CcSEcCtD
Acamprosate—Angioedema—Levothyroxine—hypothyroidism	0.00254	0.00648	CcSEcCtD
Acamprosate—GABRB3—gonad—hypothyroidism	0.00254	0.0116	CbGeAlD
Acamprosate—GRIN1—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00252	0.00646	CbGpPWpGaD
Acamprosate—Sweating—Liotrix—hypothyroidism	0.00251	0.0064	CcSEcCtD
Acamprosate—GABRB3—pituitary gland—hypothyroidism	0.00248	0.0114	CbGeAlD
Acamprosate—Palpitations—Dextrothyroxine—hypothyroidism	0.00246	0.00626	CcSEcCtD
Acamprosate—Palpitations—Levothyroxine—hypothyroidism	0.00246	0.00626	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00245	0.00629	CbGpPWpGaD
Acamprosate—Convulsion—Dextrothyroxine—hypothyroidism	0.00241	0.00614	CcSEcCtD
Acamprosate—Convulsion—Levothyroxine—hypothyroidism	0.00241	0.00614	CcSEcCtD
Acamprosate—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00237	0.00609	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00237	0.00608	CbGpPWpGaD
Acamprosate—Arthralgia—Levothyroxine—hypothyroidism	0.00237	0.00603	CcSEcCtD
Acamprosate—Arthralgia—Dextrothyroxine—hypothyroidism	0.00237	0.00603	CcSEcCtD
Acamprosate—Anxiety—Levothyroxine—hypothyroidism	0.00236	0.00601	CcSEcCtD
Acamprosate—Anxiety—Dextrothyroxine—hypothyroidism	0.00236	0.00601	CcSEcCtD
Acamprosate—Hypoaesthesia—Liotrix—hypothyroidism	0.00234	0.00596	CcSEcCtD
Acamprosate—Confusional state—Dextrothyroxine—hypothyroidism	0.00229	0.00583	CcSEcCtD
Acamprosate—Confusional state—Levothyroxine—hypothyroidism	0.00229	0.00583	CcSEcCtD
Acamprosate—GRIN2C—Neuronal System—SLC5A7—hypothyroidism	0.00228	0.00586	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00227	0.00584	CbGpPWpGaD
Acamprosate—Shock—Dextrothyroxine—hypothyroidism	0.00223	0.00569	CcSEcCtD
Acamprosate—Shock—Levothyroxine—hypothyroidism	0.00223	0.00569	CcSEcCtD
Acamprosate—Tachycardia—Dextrothyroxine—hypothyroidism	0.00222	0.00565	CcSEcCtD
Acamprosate—Tachycardia—Levothyroxine—hypothyroidism	0.00222	0.00565	CcSEcCtD
Acamprosate—GABRG2—cerebellum—hypothyroidism	0.0022	0.0101	CbGeAlD
Acamprosate—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00219	0.00559	CcSEcCtD
Acamprosate—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00219	0.00559	CcSEcCtD
Acamprosate—GABRB3—thyroid gland—hypothyroidism	0.00213	0.0098	CbGeAlD
Acamprosate—GRIN2D—Neuronal System—SLC5A7—hypothyroidism	0.00212	0.00545	CbGpPWpGaD
Acamprosate—Alopecia—Liotrix—hypothyroidism	0.00208	0.00529	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00207	0.00527	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00207	0.00527	CcSEcCtD
Acamprosate—Insomnia—Dextrothyroxine—hypothyroidism	0.00205	0.00523	CcSEcCtD
Acamprosate—Insomnia—Levothyroxine—hypothyroidism	0.00205	0.00523	CcSEcCtD
Acamprosate—Dyspnoea—Levothyroxine—hypothyroidism	0.00202	0.00516	CcSEcCtD
Acamprosate—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00202	0.00516	CcSEcCtD
Acamprosate—Flatulence—Liotrix—hypothyroidism	0.00202	0.00514	CcSEcCtD
Acamprosate—Tension—Liotrix—hypothyroidism	0.00201	0.00512	CcSEcCtD
Acamprosate—Dysgeusia—Liotrix—hypothyroidism	0.002	0.00511	CcSEcCtD
Acamprosate—Nervousness—Liotrix—hypothyroidism	0.00199	0.00506	CcSEcCtD
Acamprosate—GRIN1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00198	0.00509	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00195	0.005	CbGpPWpGaD
Acamprosate—GABRA1—cerebellum—hypothyroidism	0.00194	0.00891	CbGeAlD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00193	0.00496	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00192	0.00493	CbGpPWpGaD
Acamprosate—Tremor—Liotrix—hypothyroidism	0.00192	0.00488	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00191	0.00491	CbGpPWpGaD
Acamprosate—Agitation—Liotrix—hypothyroidism	0.00188	0.00479	CcSEcCtD
Acamprosate—Feeling abnormal—Levothyroxine—hypothyroidism	0.00187	0.00477	CcSEcCtD
Acamprosate—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00187	0.00477	CcSEcCtD
Acamprosate—Angioedema—Liotrix—hypothyroidism	0.00187	0.00476	CcSEcCtD
Acamprosate—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00186	0.00473	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00186	0.00473	CcSEcCtD
Acamprosate—Syncope—Liotrix—hypothyroidism	0.00183	0.00468	CcSEcCtD
Acamprosate—GABRB3—testis—hypothyroidism	0.00183	0.00839	CbGeAlD
Acamprosate—Palpitations—Liotrix—hypothyroidism	0.00181	0.00461	CcSEcCtD
Acamprosate—Urticaria—Dextrothyroxine—hypothyroidism	0.0018	0.0046	CcSEcCtD
Acamprosate—Urticaria—Levothyroxine—hypothyroidism	0.0018	0.0046	CcSEcCtD
Acamprosate—Loss of consciousness—Liotrix—hypothyroidism	0.0018	0.00458	CcSEcCtD
Acamprosate—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00179	0.00457	CcSEcCtD
Acamprosate—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00179	0.00457	CcSEcCtD
Acamprosate—Abdominal pain—Levothyroxine—hypothyroidism	0.00179	0.00457	CcSEcCtD
Acamprosate—Body temperature increased—Levothyroxine—hypothyroidism	0.00179	0.00457	CcSEcCtD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00178	0.00458	CbGpPWpGaD
Acamprosate—Convulsion—Liotrix—hypothyroidism	0.00177	0.00452	CcSEcCtD
Acamprosate—Hypertension—Liotrix—hypothyroidism	0.00177	0.0045	CcSEcCtD
Acamprosate—GRIN2A—Neuronal System—SLC5A7—hypothyroidism	0.00174	0.00447	CbGpPWpGaD
Acamprosate—Arthralgia—Liotrix—hypothyroidism	0.00174	0.00444	CcSEcCtD
Acamprosate—Chest pain—Liotrix—hypothyroidism	0.00174	0.00444	CcSEcCtD
Acamprosate—Anxiety—Liotrix—hypothyroidism	0.00174	0.00442	CcSEcCtD
Acamprosate—GABRB3—liver—hypothyroidism	0.00173	0.00794	CbGeAlD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0017	0.00436	CbGpPWpGaD
Acamprosate—GABRB3—cerebellum—hypothyroidism	0.00169	0.00775	CbGeAlD
Acamprosate—Confusional state—Liotrix—hypothyroidism	0.00168	0.00429	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00168	0.00431	CbGpPWpGaD
Acamprosate—Anaphylactic shock—Liotrix—hypothyroidism	0.00167	0.00425	CcSEcCtD
Acamprosate—Infection—Liotrix—hypothyroidism	0.00166	0.00423	CcSEcCtD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00166	0.00425	CbGpPWpGaD
Acamprosate—Shock—Liotrix—hypothyroidism	0.00164	0.00419	CcSEcCtD
Acamprosate—Tachycardia—Liotrix—hypothyroidism	0.00163	0.00415	CcSEcCtD
Acamprosate—Asthenia—Levothyroxine—hypothyroidism	0.00163	0.00415	CcSEcCtD
Acamprosate—Asthenia—Dextrothyroxine—hypothyroidism	0.00163	0.00415	CcSEcCtD
Acamprosate—Hyperhidrosis—Liotrix—hypothyroidism	0.00161	0.00411	CcSEcCtD
Acamprosate—Pruritus—Dextrothyroxine—hypothyroidism	0.00161	0.00409	CcSEcCtD
Acamprosate—Pruritus—Levothyroxine—hypothyroidism	0.00161	0.00409	CcSEcCtD
Acamprosate—Anorexia—Liotrix—hypothyroidism	0.00159	0.00406	CcSEcCtD
Acamprosate—Hypotension—Liotrix—hypothyroidism	0.00156	0.00398	CcSEcCtD
Acamprosate—Diarrhoea—Levothyroxine—hypothyroidism	0.00155	0.00396	CcSEcCtD
Acamprosate—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00155	0.00396	CcSEcCtD
Acamprosate—GRM5—G alpha (q) signalling events—AVP—hypothyroidism	0.00155	0.00397	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00152	0.00388	CcSEcCtD
Acamprosate—GRIN1—Neuronal System—SLC5A7—hypothyroidism	0.00152	0.0039	CbGpPWpGaD
Acamprosate—Insomnia—Liotrix—hypothyroidism	0.00151	0.00385	CcSEcCtD
Acamprosate—Paraesthesia—Liotrix—hypothyroidism	0.0015	0.00382	CcSEcCtD
Acamprosate—Dyspnoea—Liotrix—hypothyroidism	0.00149	0.00379	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—TRH—hypothyroidism	0.00148	0.00381	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—SLC5A7—hypothyroidism	0.00148	0.0038	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—NEFL—hypothyroidism	0.00147	0.00377	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00147	0.00376	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00145	0.00373	CbGpPWpGaD
Acamprosate—Decreased appetite—Liotrix—hypothyroidism	0.00145	0.0037	CcSEcCtD
Acamprosate—Vomiting—Dextrothyroxine—hypothyroidism	0.00144	0.00368	CcSEcCtD
Acamprosate—Vomiting—Levothyroxine—hypothyroidism	0.00144	0.00368	CcSEcCtD
Acamprosate—Rash—Dextrothyroxine—hypothyroidism	0.00143	0.00365	CcSEcCtD
Acamprosate—Rash—Levothyroxine—hypothyroidism	0.00143	0.00365	CcSEcCtD
Acamprosate—Dermatitis—Dextrothyroxine—hypothyroidism	0.00143	0.00364	CcSEcCtD
Acamprosate—Dermatitis—Levothyroxine—hypothyroidism	0.00143	0.00364	CcSEcCtD
Acamprosate—Constipation—Liotrix—hypothyroidism	0.00143	0.00364	CcSEcCtD
Acamprosate—Headache—Levothyroxine—hypothyroidism	0.00142	0.00362	CcSEcCtD
Acamprosate—Headache—Dextrothyroxine—hypothyroidism	0.00142	0.00362	CcSEcCtD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00138	0.00355	CbGpPWpGaD
Acamprosate—Feeling abnormal—Liotrix—hypothyroidism	0.00138	0.00351	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—NEFL—hypothyroidism	0.00137	0.00351	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Liotrix—hypothyroidism	0.00137	0.00348	CcSEcCtD
Acamprosate—Nausea—Dextrothyroxine—hypothyroidism	0.00135	0.00344	CcSEcCtD
Acamprosate—Nausea—Levothyroxine—hypothyroidism	0.00135	0.00344	CcSEcCtD
Acamprosate—Urticaria—Liotrix—hypothyroidism	0.00133	0.00338	CcSEcCtD
Acamprosate—GRM5—GPCR ligand binding—TSHB—hypothyroidism	0.00132	0.0034	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—TSHR—hypothyroidism	0.00132	0.0034	CbGpPWpGaD
Acamprosate—Abdominal pain—Liotrix—hypothyroidism	0.00132	0.00336	CcSEcCtD
Acamprosate—Body temperature increased—Liotrix—hypothyroidism	0.00132	0.00336	CcSEcCtD
Acamprosate—GABRB3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00131	0.00336	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00128	0.0033	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00128	0.00328	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00125	0.0032	CbGpPWpGaD
Acamprosate—Hypersensitivity—Liotrix—hypothyroidism	0.00123	0.00313	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.0012	0.00309	CbGpPWpGaD
Acamprosate—Asthenia—Liotrix—hypothyroidism	0.0012	0.00305	CcSEcCtD
Acamprosate—GRIN1—EPH-Ephrin signaling—VAV3—hypothyroidism	0.00119	0.00304	CbGpPWpGaD
Acamprosate—Pruritus—Liotrix—hypothyroidism	0.00118	0.00301	CcSEcCtD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VAV3—hypothyroidism	0.00116	0.00297	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.00114	0.00293	CbGpPWpGaD
Acamprosate—Diarrhoea—Liotrix—hypothyroidism	0.00114	0.00291	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00112	0.00288	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—NEFL—hypothyroidism	0.00112	0.00288	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00112	0.00288	CbGpPWpGaD
Acamprosate—Dizziness—Liotrix—hypothyroidism	0.0011	0.00281	CcSEcCtD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0011	0.00283	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00108	0.00278	CbGpPWpGaD
Acamprosate—Vomiting—Liotrix—hypothyroidism	0.00106	0.00271	CcSEcCtD
Acamprosate—Rash—Liotrix—hypothyroidism	0.00105	0.00268	CcSEcCtD
Acamprosate—Dermatitis—Liotrix—hypothyroidism	0.00105	0.00268	CcSEcCtD
Acamprosate—Headache—Liotrix—hypothyroidism	0.00105	0.00267	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—SLC5A7—hypothyroidism	0.001	0.00257	CbGpPWpGaD
Acamprosate—Nausea—Liotrix—hypothyroidism	0.000992	0.00253	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—SLC5A7—hypothyroidism	0.000985	0.00253	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—NEFL—hypothyroidism	0.000979	0.00251	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000963	0.00247	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—NEFL—hypothyroidism	0.000955	0.00245	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—CLTC—hypothyroidism	0.000935	0.0024	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—CLTC—hypothyroidism	0.000911	0.00234	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.0009	0.00231	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.000861	0.00221	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000843	0.00216	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—VAV3—hypothyroidism	0.000843	0.00216	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—TRH—hypothyroidism	0.000839	0.00215	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000828	0.00213	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—VAV3—hypothyroidism	0.000821	0.00211	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—AVP—hypothyroidism	0.00078	0.002	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—TRH—hypothyroidism	0.000762	0.00196	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000761	0.00195	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—TSHB—hypothyroidism	0.000748	0.00192	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—TSHR—hypothyroidism	0.000748	0.00192	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000724	0.00186	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—TSHB—hypothyroidism	0.000679	0.00174	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—TSHR—hypothyroidism	0.000679	0.00174	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CLTC—hypothyroidism	0.000667	0.00171	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CLTC—hypothyroidism	0.00065	0.00167	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—NEFL—hypothyroidism	0.000646	0.00166	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—NEFL—hypothyroidism	0.000634	0.00163	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000581	0.00149	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—VAV3—hypothyroidism	0.000556	0.00143	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000555	0.00142	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000539	0.00138	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000529	0.00136	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CLTC—hypothyroidism	0.000521	0.00134	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—POMC—hypothyroidism	0.000518	0.00133	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000463	0.00119	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000458	0.00117	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—VAV3—hypothyroidism	0.000457	0.00117	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TRH—hypothyroidism	0.00045	0.00116	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000447	0.00115	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AVP—hypothyroidism	0.000441	0.00113	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VAV3—hypothyroidism	0.00044	0.00113	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000439	0.00113	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000431	0.00111	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VAV3—hypothyroidism	0.000429	0.0011	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—VAV3—hypothyroidism	0.000415	0.00107	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TSHB—hypothyroidism	0.000401	0.00103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TSHR—hypothyroidism	0.000401	0.00103	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AVP—hypothyroidism	0.0004	0.00103	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000383	0.000984	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SH2B3—hypothyroidism	0.000358	0.000918	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VAV3—hypothyroidism	0.000314	0.000807	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VAV3—hypothyroidism	0.000306	0.000786	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—POMC—hypothyroidism	0.000293	0.000752	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—POMC—hypothyroidism	0.000266	0.000683	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRL—hypothyroidism	0.000265	0.000681	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VAV3—hypothyroidism	0.000245	0.00063	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AVP—hypothyroidism	0.000236	0.000607	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000215	0.000553	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000212	0.000543	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000185	0.000475	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00017	0.000435	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000167	0.000428	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—POMC—hypothyroidism	0.000157	0.000403	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—hypothyroidism	0.000151	0.000388	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000146	0.000374	CbGpPWpGaD
